How many patents does
Rosalind Franklin University Of Medicine And Science have?
patents
130
families
37
granted
37
applications
93
US
69
WO
21
EP
16
JP
6
CN
3
GB
2
RoW
13
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Rosalind Franklin University Of Medicine And Science
Top ten assignees appearing on patents
2009 - 2018
| isis pharmaceuticals | 6 |
| ionis pharmaceuticals | 6 |
| ribonomics | 3 |
| biosensics | 2 |
| leishvac | 2 |
2009
| ribonomics | 1 |
2018
Rosalind Franklin University Of Medicine And Science
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| compounds for stabilizing ryanodine receptors from aberrant levels of calcium release | 16 | 2013 |
| ccn3 peptides and analogs thereof for therapeutic use | 14 | 2010 |
| regulation of ccn2 by ccn3 and its therapeutic and diagnostic potential in fibrosis, scl… 🛈 | 8 | 2005 |
| kits for determining male fertility by measuring levels of a2v-atpase, g-csf, mip 1 alph… 🛈 | 8 | 2013 |
| antisense compounds targeting genes associated with cystic fibrosis | 6 | 2015 |
| antisense compounds and uses thereof | 6 | 2013 |
| antisense oligonucleotides that target a cryptic splice site in ush1c as a therapeutic f… 🛈 | 6 | 2010 |
| facilitation of resuscitation from cardiac arrest by erythropoietin | 5 | 2006 |
| antisense compounds targeting leucine-rich repeat kinase 2 (lrrk2) for the treatment of … 🛈 | 5 | 2015 |
| compounds for reversing and inhibiting protein aggregation, and methods for making and u… 🛈 | 4 | 2008 |